www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/aktien/Nebenwerte-der-Woche-Zockerwerte-im-Fokus-774880<i>von Benjamin Summa</i> Die B&ouml;rsen laufen weiter. R&uuml;ckenwind gab es vergangene Woche von der gestarteten Quartalssaison in den USA – die Gewinne sprudeln wieder. Viele Investoren, die noch nicht ausreichend eingedeckt waren, hoffen jetzt ...http://www.finanzen.net/nachricht/aktien/Nebenwerte-der-Woche-Zockerwerte-im-Fokus-774880http://www.finanzen.net/nachricht/aktien/Biotech-Genta-Deutschlands-meistgesuchte-Zocker-Aktie-671539Genta ist nun keine Aktie, die unter deutschen Anlegern sonderlich bekannt ist. Im Gegenteil, der Pennystock f&uuml;hrt ein ziemliches Schattendasein. Sollte man meinen. Doch unter Zockern ist der amerikanische Biotech-Wert durchaus ein Bergriff. In den ...http://www.finanzen.net/nachricht/aktien/Biotech-Genta-Deutschlands-meistgesuchte-Zocker-Aktie-671539http://www.finanzen.net/nachricht/aktien/Genta-Announces-Allowance-of-Two-Key-European-Patents-for-Genasense-475860 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Genta Incorporated (OTCBB:GNTA.OB) announced today that the European Patent Office intends to grant ...http://www.finanzen.net/nachricht/aktien/Genta-Announces-Allowance-of-Two-Key-European-Patents-for-Genasense-475860http://www.finanzen.net/nachricht/aktien/Genta-Announces-Presentations-for-Two-Lead-Compounds-Genasense-and-Tesetaxel-at-2009-Annual-ASCO-Meeting-473528 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Genta Incorporated (OTCBB: GNTA.OB) announced today that data from clinical trials of the Company's ...http://www.finanzen.net/nachricht/aktien/Genta-Announces-Presentations-for-Two-Lead-Compounds-Genasense-and-Tesetaxel-at-2009-Annual-ASCO-Meeting-473528http://www.finanzen.net/nachricht/aktien/Genta-Announces-Completion-of-Patient-Enrollment-into-Global-Phase-3-Trial-of-Genasense-in-Advanced-Melanoma-466357 <style type="text/css"> <!-- .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingright0 {padding-right: 0.0px} .bwcellparagraphmargin {margin-bottom: 0px; margin-top: 0px} .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwsinglebottomborder {border-bottom: ...http://www.finanzen.net/nachricht/aktien/Genta-Announces-Completion-of-Patient-Enrollment-into-Global-Phase-3-Trial-of-Genasense-in-Advanced-Melanoma-466357http://www.finanzen.net/nachricht/aktien/Genta-Secures-Up-to-12-Million-in-Convertible-Debt-Financing-464844 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Genta Incorporated (OTCBB: GNTA.OB) announced today that the Company has entered into definitive agreements ...http://www.finanzen.net/nachricht/aktien/Genta-Secures-Up-to-12-Million-in-Convertible-Debt-Financing-464844http://www.finanzen.net/nachricht/aktien/FDA-Appeal-Decision-Indicates-that-Genasense-Approval-in-Chronic-Lymphocytic-Leukemia-Will-Require-Additional-Confirmatory-Trial-452738 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Genta Incorporated (NASDAQ: GNTA) announced that the Food and Drug Administration’s (FDA) Center for ...http://www.finanzen.net/nachricht/aktien/FDA-Appeal-Decision-Indicates-that-Genasense-Approval-in-Chronic-Lymphocytic-Leukemia-Will-Require-Additional-Confirmatory-Trial-452738http://www.finanzen.net/nachricht/aktien/Genta-Incorporated-Announces-Fourth-Quarter-and-Year-End-2008-Financial-Results-and-Corporate-Highlights-443922 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft4 {padding-left: 20.0px} .bwcellpaddingright0 {padding-right: 0.0px} .bwcellparagraphmargin ...http://www.finanzen.net/nachricht/aktien/Genta-Incorporated-Announces-Fourth-Quarter-and-Year-End-2008-Financial-Results-and-Corporate-Highlights-443922http://www.finanzen.net/nachricht/aktien/Genta-Submits-Randomized-Study-of-Tesetaxel-in-Patients-with-Advanced-Gastric-Cancer-to-FDA-for-Special-Protocol-Assessment-442509 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Genta Incorporated (OTCBB: GNTA) announced today that the Company has submitted a proposal to the ...http://www.finanzen.net/nachricht/aktien/Genta-Submits-Randomized-Study-of-Tesetaxel-in-Patients-with-Advanced-Gastric-Cancer-to-FDA-for-Special-Protocol-Assessment-442509http://www.finanzen.net/nachricht/aktien/Genta-Incorporated-to-Release-Fourth-Quarter-Financial-Results-and-Host-Conference-Call-441237 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> Genta Incorporated (OTCBB: GNTA) announced today that the Company will release its financial results ...http://www.finanzen.net/nachricht/aktien/Genta-Incorporated-to-Release-Fourth-Quarter-Financial-Results-and-Host-Conference-Call-441237